A more complete understanding of the transcriptional control of the human and murine class I MHC receptors will help to shed light on the mechanism of selective, stochastic, gene activation that operates in these gene families. Studies of the murine Ly49 class I MHC receptor genes have revealed an important role for distal transcripts originating upstream of the proximal promoter. To date, there have been no reports of distal promoters within the functionally analogous human KIR family of class I MHC receptors. In the current study, reverse transcriptase-polymerase chain reaction (RT-PCR) and RNase protection assays were used to reveal the presence of distal KIR transcripts initiating upstream of the previously characterized proximal KIR promoter. The intergenic promoter elements detected were associated with repetitive elements of the Alu and L1 families. Unlike the proximal KIR promoter, the distal promoter regions were not NK cell-specific. KIR genes expressed in a variegated manner produced a low level of distal transcripts containing a large 5 0 untranslated region. In contrast, the highly expressed KIR2DL4 gene possessed a higher level of spliced distal transcripts that were capable of producing KIR2DL4 protein. The identification of distal KIR promoter elements suggests that intergenic transcripts may influence the expression of KIR genes.
Introduction
Natural killer (NK) cells are large granular lymphocytes that have the ability to eliminate tumors and virusinfected cells. 1 NK cells sense the state of potential target cells through the integration of signals received from activating receptors recognizing stress-related changes and the opposing signals generated by inhibitory receptors that recognize major histocompatibility complex (MHC) class I molecules. 2 The killer cell immunoglobulin-like receptor (KIR) genes constitute a major family of MHC receptors expressed by human NK cells. 3 There are two functionally distinct types of KIR, the activating and inhibitory receptors. The inhibitory KIR have been shown to recognize specific human leukocyte antigen (HLA) molecules, while the precise nature of the ligands for the activating KIR is still being explored. 4 KIR expression is variegated, enabling NK cells to distinguish subtle changes in HLA expression. [5] [6] [7] Variegated expression is beneficial, since virus infection or transformation might only downregulate one HLA allele, and the presence of NK cells that express a subset of inhibitory HLA receptors allows the detection of cells that have altered expression of a single type of HLA molecule. Variation in the number and type of KIR genes present in an individual genotype leads to a wide array of KIR repertoires in the human population. 7 Stochastic activation of KIR genes leads to distinct percentages of NK cells that express a given KIR. The mechanism governing selective expression of KIR genes is not completely understood.
The current hypotheses explaining variegated expression of KIR genes are based on the methylation state of active versus silent KIR alleles. Three separate studies observed that non-expressed KIR alleles are methylated, while treatment with the demethylating agent 5-aza-2-deoxycytidine (5-aza) resulted in the de novo expression of KIR genes. [8] [9] [10] How methyltransferases are recruited and what governs selective methylation is unknown, and studies have focused on the KIR promoter elements.
A promoter identified in the 5 0 region adjacent to the translational start site has been characterized for many KIR genes, and the possible association of distinct promoter properties with the mechanism of variegated expression has been discussed. [11] [12] [13] [14] [15] The KIR2DL4 gene is unique in that it is expressed by all NK cells, and given this property, the KIR2DL4 promoter has been analyzed by in vitro promoter assays and DNA footprinting in order to compare it with the promoters of the variegated KIR genes. 11 The KIR2DL4 gene is also unique since it has a 14 kb intergenic region upstream from the translational start site, in contrast to the approximately 2 kb that separates the other KIR genes. 16 In addition, KIR2DL4 expression is restricted to NK cells, and in vitro promoter assays did not detect appreciable activity of the KIR2DL4 promoter in the Jurkat T-cell line. 11 Comparison of KIR2DL4 with KIR3DL1 revealed differences in predicted transcription factor-binding sites and promoter activity. All of the expressed KIR genes possess a binding site for the AML family of transcription factors that is located approximately 98 bp upstream from the ATG start site, and the AML-2 (Runx3) protein has been shown to bind this element. 12, 13, 15 The potential importance of the AML site has been revealed by studies of KIR2DL5 alleles. 17 Two non-expressed KIR2DL5 gene variants, KIR2DL5.2 and -5.4, have a single base pair change that disrupts the AML site, while the expressed -5.1 and -5.3 variants have this site intact. Additional in vitro studies have shown that disruption of the AML-binding site in several KIR genes significantly reduced, but did not abolish promoter activity, suggesting that AML might play a role in the opening of the locus in vivo. [13] [14] [15] Several studies have examined the KIR intergenic region in order to identify elements regulating promoter activity. 11, 12, 14 When the full 2 kb intergenic region was tested, no additional activity was observed relative to the smallest active fragment contained within 267 bp of the ATG start site. 11 As an additional upstream bi-directional switch promoter has been associated with the stochastic expression of the murine Ly49 class I MHC receptors, 18 we conducted a detailed investigation of KIR RNAs initiated upstream of the known promoter, and the KIR intergenic regions were analyzed for additional promoter elements.
Results

Detection of KIR intergenic transcripts
The possible presence of intergenic transcripts in the KIR gene cluster was investigated by performing reverse transcriptase-polymerase chain reaction (RT-PCR) on RNA from purified human NK cells with a series of 5 0 primers contained within the KIR2DL4-KIR3DL1 intergenic region together with a 3 0 primer in exon 4 of the KIR3DL1 gene ( Figure 1 ). Primers starting at 255, 627, 756 and 835 bp upstream of the KIR3DL1 start codon were capable of generating spliced cDNAs containing exons 1-4 preceded by continuous, unspliced 5 0 intergenic sequence. Primers located further upstream were unable to produce the predicted products. All of the PCR products were cloned and sequenced, and the predicted spliced KIR3DL1 RNAs containing 5 0 intergenic sequence were identified. These results demonstrate the presence of RNA transcripts originating from upstream elements, and suggest that transcription from an upstream promoter element initiates between 835 and 911 bp upstream of the KIR3DL1 start codon.
Characterization of the KIR3DL1 distal promoter element As RT-PCR experiments indicated the possible presence of an additional KIR3DL1 promoter in the intergenic region containing flanking AluSx and L1M5 repetitive elements (Figure 1 ), a series of fragments spanning these repetitive elements was generated by PCR and cloned into pGL3. Constructs were transfected into the YT-Indy cell line and relative promoter activity was measured. As shown in Figure 2 , weak promoter activity was found in the KIR3DL1 upstream region associated with fragments that contained both of the adjacent L1M5 and AluSx repetitive elements. Removal of the 3 0 AluSx element (fragment À1347 to À887) containing Ets and NF-E2 sites abolished promoter activity, and the removal of the 5 0 Myc/AML and USF transcription factor-binding sites contained within the L1M5 element decreased activity by approximately 50% (fragment À1097 to À819). acterized promoters, a ribonuclease protection assay (RPA) was performed on RNA isolated from peripheral blood NK cells and the NK92 cell line using antisense KIR3DL1, KIR2DL2 or KIR2DL4 probes ( Figure 3 ). The KIR2DL2 probe was used for the detection of KIR transcripts in ex vivo NK cells, since we found that the level of transcripts detected with this probe were significantly higher than KIR3DL1 transcripts, and therefore allowed detection of the low level of transcripts present in fresh NK cells. In order to study KIR transcripts in NK92 cells, it was necessary to induce demethylation with 5-aza-2-deoxycytidine (5-aza), since the KIR2DL4 gene is the only family member expressed by this cell line, and treatment with 5-aza is required to induce expression of the other KIR genes. [8] [9] [10] As shown in Figure 3a , KIR3DL1 and KIR2DL2 proximal transcripts were only detected in NK92 cell RNA derived from 5-aza-treated cells. Numerous start sites of proximal transcripts were detected, consistent with previous studies performed by conducting 5'-RACE on KIR transcripts. 11, 14, 17, 19 However, the RPA analysis indicates that a preferred transcription start site is located 58 nucleotides upstream of the KIR3DL1 start codon. Interestingly, a TATAAA-like element (TGTAAA) is located 25 nucleotides upstream of the major start site. A nearly identical pattern of KIR start sites was observed in NK92 and sorted KIR-positive NK cells with probes from the KIR2DL1, KIR2DL2 and KIR3DL1 5 0 regions (Figure 3a and data not shown). Additional protected RNA fragments corresponding to transcripts initiated further upstream were detected at a much lower level. The full KIR3DL1 probe sequence was protected as well as a slightly shorter RNA corresponding to a spliced RNA lacking the first five nucleotides of intron 1 contained in the probe. The full-length protected probe potentially represents unspliced KIR3DL1 RNA; however, there may be some contribution of contaminating genomic DNA to this band even though the RNA samples were treated with DNase before RPA analysis. The RPA analysis of KIR2DL4 transcripts is shown in 
Identification of a distal KIR2DL4 promoter
The region flanking the 5 0 end of the novel KIR2DL4 transcript start site was tested for promoter activity in luciferase reporter assays (Figure 4) . The 3 0 ends of the promoter fragments tested were located 50 bp downstream from the predicted transcription start site. The start site of the distal promoter was predicted by the 5 0 end of a human EST clone (GenBank #DA590865) that was derived using the oligo-capping method which preferentially clones cDNAs containing the 5 0 end of mRNAs. 20 The largest fragment analyzed (11 143 to 10 483 bp upstream of the KIR2DL4 start codon) contained putative Yy1 and AML-binding sites. This construct exhibited the highest level of promoter activity; however a similar level of activity was seen with a smaller fragment (10 713-10 483) that contains predicted Irf-1 and Ets-binding sites. Fragments containing the region from 11 143 to 10 925 and from 10 925 to 10 713 bp did not demonstrate any promoter activity, indicating that the core promoter is located in the 10 713-10 483 region. As a previous report has demonstrated IL-2-regulation of KIR2DL4 expression, 21 we tested the effect of IL-2 on transcription from the KIR2DL4 distal promoter. Treatment of transfected cells with IL-2 (1000 U/ml) had no effect on distal promoter activity (data not shown).
Promoter activity is associated with repetitive elements in several KIR genes Due to the high homology of the KIR intergenic regions, similar repetitive elements are present in all members of the KIR gene family. Figure 5 shows the promoter activity detected in fragments containing repetitive elements present in a similar location in the intergenic region preceding the KIR2DL4, KIR2DL5 and KIR3DL3 genes. Fragments isolated from the homologous region preceding the KIR2DL5 gene possessed very weak promoter activity, possibly due to the lack of a 3 0 Etsbinding site present in the KIR3DL1 distal promoter region. Fragments generated from a similar location in the KIR2DL4 gene possessed promoter activity that was two-to four-fold greater than the KIR3DL1 activity detected in YT-Indy and HEK293T cell lines. In order to determine if transcripts from this additional distal KIR2DL4 promoter (distal-2) could also be spliced to the proximal region, PCR was performed with a primer near the 3 0 end of the active promoter fragment. A distal Distal KIR promoters MJ Stulberg et al KIR2DL4 transcript containing the region adjacent to the distal-2 promoter spliced to the acceptor site at À190 (Figure 3b ) was identified, demonstrating that transcripts originating from either of the two distal 2DL4 promoters could be spliced to the proximal promoter region. The KIR2DL4 distal-1 promoter activity detected in the YTIndy cell line was slightly higher than the activity observed in HEK293T and Jurkat cells, indicating the possible contribution of NK-specific transcription factors to the activity of this promoter. The intergenic region preceding the KIR3DL3 gene contains an L1 repeat in the forward direction and this element possessed even greater promoter activity when cloned into pGL3 in the same orientation as the KIR3DL1, KIR2DL5 and KIR2DL4 elements. In all cases, no promoter activity was detected when the fragments were cloned into pGL3 such that the repetitive elements were in the opposite orientation (data not shown). With the exception of the KIR2DL4 distal-1 promoter, the upstream promoter elements identified were not NK cell-specific, since higher promoter activity was found in HEK293T cells than the YT-Indy NK line.
Functional relevance of the upstream KIR2DL4 transcripts The detection of a significant level of KIR2DL4 transcripts originating upstream of the proximal promoter (Figure 3b ) suggests that these transcripts might contribute to KIR expression. Since two distal KIR2DL4 promoters were identified, primers adjacent to each of these promoters were used with a 3 0 primer containing the KIR2DL4 stop codon to amplify transcripts containing the full KIR2DL4 coding region. PCR products were cloned into the pEF6/v5-His-Topo expression vector and verified by DNA sequencing. Expression constructs containing proximal and distal cDNAs were transfected into HEK293T cells and intracellular expression was detected with a KIR2DL4-specific monoclonal antibody. 22 As shown in Figure 6 , the alternative transcripts were capable of producing KIR2DL4 protein at levels similar to those observed with the proximal promoter transcripts.
Discussion
Comparative analysis of the transcriptional control of the KIR3DL1 and KIR2DL4 genes should yield insights into the molecular mechanisms underlying NK cell expression and selective gene activation, since the KIR3DL1 gene is expressed in a variegated fashion whereas the KIR2DL4 gene is expressed by all NK cells. A previous study revealed differences in transcription factor binding and tissue-specific promoter activity of these two genes. 11 The search for specific differences in the KIR2DL4 gene that might explain the lack of variegated expression displayed by other KIR family members has not yet indicated a candidate element to explain the distinct behavior of these genes. The initial sequence analysis of the KIR gene cluster did however reveal one significant difference: the KIR2DL4 gene lacks the large array (23-63 copies) of 19-20 bp nucleotide repeats found in the first intron of all other KIR genes. 16 The functional relevance of these repeats has yet to be directly tested, however, one intriguing possibility is their potential involvement in a gene silencing mechanism, since repetitive DNA sequences have been linked to RNA-mediated pathways of gene silencing. 23 The current study has revealed an additional difference between KIR2DL4 and the variegated KIR genes; KIR2DL4 possesses an additional promoter 10 kb upstream that produces spliced mRNAs capable of expressing KIR2DL4 protein.
The discovery of additional promoter elements upstream of the previously characterized proximal KIR promoter indicates a possible role of intergenic transcription in the regulation of KIR gene expression. Studies of the regulation of cytokine gene clusters have also revealed the presence of many intergenic transcripts, and additional promoter elements. 24, 25 The additional upstream promoters identified in the KIR genes are associated with repetitive elements, and do not behave in a tissue-specific manner. Alu repeats within the human b-globin gene cluster have been shown to play a role in the silencing of fetal g-globin during adult erythropoiesis, and a recent report has implicated Dicer-mediated silencing as a mechanism associated with the loss of fetal hemoglobin expression during development. 26 The possible role of distal KIR transcripts in generating doublestranded RNA in conjunction with a recently discovered antisense KIR transcript is currently under investigation. (SK Anderson, unpublished data).
An upstream bi-directional promoter complex (Pro1) specifically active in immature NK cells was shown to be required for gene activation in the murine Ly49 cluster of class I MHC receptor genes. 18, 27 The mechanism of gene activation in the KIR genes should be distinct however, since the upstream KIR promoter elements are neither NK cell-specific nor bi-directional switch elements. The model of variegated Ly49 gene expression proposes that the Pro1 element chooses between transcription toward or away from the gene in a probabilistic fashion, and forward transcripts result in the opening of the proximal promoter region required for expression in mature NK cells. In contrast, the proximal promoter in the KIR genes is bi-directional. KIR alleles with a high ratio of forward to reverse proximal promoter activity are expressed on a higher percentage of NK cells than KIR alleles with a low ratio of forward to reverse promoter activity (SK Anderson, manuscript in preparation). Perhaps antisense transcripts produced by the proximal promoter can associate with distal sense transcripts, leading to the production of double-stranded RNA and siRNAmediated silencing of the KIR proximal promoter. In this respect, it is notable that the KIR2DL4 gene produces spliced distal transcripts that can express KIR2DL4 protein, perhaps bypassing control mechanisms operating on the proximal promoter region.
Distal-2 Vector Figure 6 KIR2DL4 distal transcripts are translatable. The two distal and the proximal KIR2DL4 transcripts were generated by RT-PCR and cloned into the pEF6/v5-His-Topo expression vector. Constructs were transfected into HEK293T cells and intracellular staining was performed with the mAb33 antibody on permeabilized, fixed cells following the protocol of Rajagopalan et al.
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The discovery of intergenic KIR promoters and transcripts opens new avenues of investigation into the possible mechanisms that control the allele-specific methylation of the variegated KIR genes. Future work on the production of siRNA and potential links to KIR gene methylation may provide important insights into the regulation of KIR expression.
Materials and methods
Cell lines HEK293T cells were cultured in Dulbecco's modified Eagle medium containing 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 U/ml streptomycin (P/S), sodium pyruvate, and L-glutamine. NK92 cells were cultured in RPMI 1640 media containing 10% FBS, nonessential amino acids, b-mercaptoethanol, P/S, sodium pyruvate, L-glutamine, HEPES, and 1000 U/ml of recombinant human IL-2. YT-Indy and Jurkat cells were cultured in RPMI 1640 media containing 10% FBS, P/S, and L-glutamine. 
Preparation of blood NK cells
RT-PCR of KIR transcripts
Total RNA was isolated from peripheral blood NK cells with the RNeasy kit (Qiagen, Valencia, CA, USA) and 5.0 mg was used to generate cDNA using the SuperscriptII first-strand cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA). Approximately 5% of the resulting cDNA was used per PCR reaction with a series of 24 nucleotide primers at the intergenic positions indicated in Figure 1 
RNase protection assays
The RNase protection assay (RPA) was performed according to the manufacturer's protocol using an RPA kit (RPA II; Ambion, Austin, TX, USA). The probe regions chosen ( Figure 1) were generated from genomic DNA by PCR and cloned into the pCR4-TOPO vector. Insert containing the flanking T7 polymerase-binding site was obtained by digestion with PmeI and FspI restriction enzymes. In vitro transcription was performed according to the manufacturer's protocols using the T7 MAXIscript (Ambion) in vitro transcription kit. The [a-32 P]RNA was separated on a 6% denaturing polyacrylamide gel and the full-length probe was excised and eluted by overnight incubation at 371C in gel elution buffer (Ambion). Approximately 1 Â 10 5 cpm of the gelpurified probe was added to 20 mg of total RNA in each reaction mixture. The protected RNA products were separated on an 8% denaturing polyacrylamide gel. The gel was dried and exposed for B24 h in a PhosphorImager cassette (Molecular Dynamics, Sunnyvale, CA, USA). The image was visualized using PhosphorImager SI analysis and ImageQuaNT (Molecular Dynamics).
Generation of luciferase reporter constructs
Promoter fragments were generated by PCR using oligonucleotide primers and cloned into the pCR2.1-Topo vector (Invitrogen). Inserts were excised with either SacI/XhoI or XhoI/HindIII enzymes and cloned into the pGL3-basic firefly luciferase reporter vector (Promega, Madison, WI, USA), to create constructs with the insert in either the forward or reverse orientation.
Cell transfection and luciferase assays YT-Indy and Jurkat cells were transfected by electroporation using a BTX ECM 830 (Genetronics, San Diego, CA, USA). YT-Indy transfections included a total of 5 Â 10 6 cells in serum free RPMI medium with 10 mg of pGL3 constructs plus 100 ng of Renilla luciferase pRL-SV40 vector and electroporated at 250 mV, with three pulses of 7 ms at an interval of 100 ms. Jurkat transfections used a total of 1 Â 10 7 cells in serum-free RPMI medium with 30 mg of luciferase construct plus 1 mg of pRL-SV40 vector and electroporated at 300 mV, with 1 pulse of 10 ms. HEK293T cells were transfected using FuGene 6 (Roche Molecular Biochemicals, Indianapolis, IN, USA) following the manufacturer's protocol. Luciferase activity was assayed at 48 h (YT-Indy, HEK293 T) and 24 h (Jurkat) using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. Firefly luciferase activity was normalized relative to the Renilla luciferase activity for each transfection.
KIR2DL4 Expression vectors
RNA was isolated from NK92 cells with the RNeasy kit (Qiagen) and 0.5 mg was used to generate cDNA using the SuperscriptII first-strand cDNA synthesis kit (Invitrogen). Oligonucleotide primers specific for distinct KIR2DL4 5 0 -untranslated regions were used together with a 3 0 primer containing the KIR2DL4 stop codon to generate PCR fragments that were subsequently cloned into the pEF6/ v5-His-Topo expression vector (Invitrogen). Expression vectors were transfected into HEK293T cells using FuGene 6, and KIR2DL4 protein expression was visualized using the mAb33 antibody on permeabilized, fixed cells following the protocol of Rajagopalan et al.
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